Literature DB >> 10070685

Mixture models for cancer survival analysis: application to population-based data with covariates.

R De Angelis1, R Capocaccia, T Hakulinen, B Soderman, A Verdecchia.   

Abstract

The interest in estimating the probability of cure has been increasing in cancer survival analysis as the curability of many cancer diseases is becoming a reality. Mixture survival models provide a way of modelling time to death when cure is possible, simultaneously estimating death hazard of fatal cases and the proportion of cured case. In this paper we propose an application of a parametric mixture model to relative survival rates of colon cancer patients from the Finnish population-based cancer registry, and including major survival determinants as explicative covariates. Disentangling survival into two different components greatly facilitates the analysis and the interpretation of the role of prognostic factors on survival patterns. For example, age plays a different role in determining, from one side, the probability of cure, and, from the other side, the life expectancy of fatal cases. The results support the hypothesis that observed survival trends are really due to a real prognostic gain for more recently diagnosed patients.

Entities:  

Keywords:  Age Factors; Cancer; Causes Of Death; Demographic Factors; Developed Countries; Diseases; Europe; Finland; Length Of Life; Life Expectancy; Models, Theoretical; Mortality; Neoplasms; Northern Europe; Population; Population Characteristics; Population Dynamics; Research Methodology; Scandinavia; Survivorship--determinants

Mesh:

Year:  1999        PMID: 10070685     DOI: 10.1002/(sici)1097-0258(19990228)18:4<441::aid-sim23>3.0.co;2-m

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  27 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

2.  A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.

Authors:  Tim S Grant; Darren Burns; Christopher Kiff; Dawn Lee
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

3.  Projections of the cost of cancer care in the United States: 2010-2020.

Authors:  Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2011-01-12       Impact factor: 13.506

4.  Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.

Authors:  Gaya Spolverato; Fabio Bagante; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Emily Winslow; Clifford Cho; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

5.  Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer.

Authors:  Angela B Mariotto; Zhaohui Zou; Fanni Zhang; Nadia Howlader; Allison W Kurian; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-18       Impact factor: 4.254

6.  Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

Authors:  Theodora Bejan-Angoulvant; Anne-Marie Bouvier; Nadine Bossard; Aurelien Belot; Valérie Jooste; Guy Launoy; Laurent Remontet
Journal:  Eur J Epidemiol       Date:  2008-02-09       Impact factor: 8.082

7.  Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.

Authors:  Tomáš Pavlík; Ondřej Májek; Jan Mužík; Jana Koptíková; Lubomír Slavíček; Jindřich Fínek; David Feltl; Rostislav Vyzula; Ladislav Dušek
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

8.  What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?

Authors:  M Abdel-Rahman; D Stockton; B Rachet; T Hakulinen; M P Coleman
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

9.  The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study.

Authors:  Li-Jen Liao; Hsu-Wen Chou; Chi-Te Wang; Chen-Shuan Chung; Mei-Shu Lai
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Modeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimates.

Authors:  Irene Rocchetti; Domenica Taruscio; Daniela Pierannunzio
Journal:  BMC Neurol       Date:  2012-12-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.